Dan Loeb discloses Snowflake among his latest winning investments
Dan Loeb, the billionaire activist investor, founder, and CEO of Third Point LLC disclosed that one of his latest winning investments is Snowflake (NYSE:...
Facebook (FB) Stock Presents a Buying Opportunity as it Starts Moving Upwards
Facebook (NASDAQ: FB) shares suffered a significant decline last year due to a series of negative reports particularly its mishandling of users’ personal information.
This...
SpaceX Launches The first Falcon Heavy Mission In Over Three Years
Elon Musk’s SpaceX on Tuesday launched the first Falcon Heavy mission in over three years, a towering rocket that is the most robust in...
Hertz invests big in electric vehicle rental fleet; orders 100K Tesla EVs
Hertz Corporation is ordering 100,000 electric vehicles (EVs) from Tesla Inc (NASDAQ: TSLA) by the end of 2022 and new EV charging infrastructure across...
Ripple CEO addresses SEC lawsuit, alleges Tetragon of exploitation
Ripple CEO Brad Garlinghouse answered questions regarding the SEC's lawsuit against the company on Twitter. He addressed five key areas in the case including...
Colorado joins DOJ settlement over T-Mobile-sprint merger
The U.S. Department of Justice (DOJ) announced that Colorado is joining its settlement to resolve the claims against related to the proposed T-Mobile-Sprint merger.
Florida,...
Toms Donates 5 Million Dollars to End Gun Violence
A popular footwear company is donating 5 million dollars to end gun violence. Toms founder, Blake Mycoskie, appeared on the Late Show With Jimmy...
Haribo Sent Candies to a Man Who Returned Their $4 Million Lost Check Candies
Candies are what you’ll get for returning an almost $5 million lost check to a company.
A man in Germany found a lost check for...
Zuckerberg advice at Harvard graduation speech – “drop out and start a business.”
Mark Zuckerberg is about to give the graduation speech at Harvard. Considering that Zuckerberg dropped out of Harvard, just like Bill Gates, and both...
Sandoz Triumphs in Incontinence IP Battle Against Astellas
Astellas has successfully defended one of its U.K. patents against two generic drug manufacturers in a high-stakes courtroom battle over a treatment for overactive...